FAMPRIDIN-TTS

European patent · EP3651744 · In force

Register entry

Publication number
EP3651744
Application number
EP18740809
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 12, 2018
Published
May 20, 2020
Granted
Oct 19, 2022
Protection ends at the latest
Jul 11, 2038
Next annual fee due
Jul 31, 2027
IPC classes
A61K 9/70 (2006.01)
A61K 31/4409 (2006.01)
A61P 25/28 (2006.01)
Priority
DE 102017115701 12.07.2017
PCT application
PCT/EP2018/068952 12.07.2018
PCT publication
WO2019/012047 17.01.2019
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 5, 2024

    Change

    Published in Swissreg on 05.08.2024

  4. Aug 30, 2023

    Change

    Published in Swissreg on 30.08.2023

  5. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  6. Dec 14, 2022

    Agent entered

    Representative
    Felber und Partner AG, Dufourstrasse 116, 8008 Zürich

    Published in Swissreg on 14.12.2022

  7. Oct 19, 2022

    Granted

    Published in Swissreg on 19.10.2022

Parties

Holder

LTS Lohmann Therapie-Systeme AG

Lohmannstraße 2, 56626 Andernach, DE

Agent

Felber und Partner AG

Dufourstrasse 116, 8008 Zürich

Inventor

KEIKERT, Rosemarie

56626 Andernach, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.